Middendorf D, Grantham J
J Lab Clin Med. 1985 Oct;106(4):455-60.
Vanadate, furosemide, chlorothiazide, acetazolamide, and amiloride were infused concomitantly into conscious rats to determine the extent to which renal sodium reabsorption can be inhibited. The animals were maintained in exact fluid balance despite exorbitant urine flow rates by intravenous infusion of an isotonic salt solution sufficient to keep body weight constant. In maximally effective doses vanadate, furosemide, chlorothiazide, acetazolamide, and amiloride increased sodium excretion to an amount equal to 69% of the filtered load. Together with isotonic extracellular fluid expansion equal to 7% of body weight, these pharmacologic agents increased sodium excretion to an amount equal to 83.7% of the filtered load, a level of sustained sodium excretion that has not been reported previously in mammals. These studies demonstrate that tubular sodium and water reabsorption can be profoundly inhibited in vivo by drugs that diminish sodium and water transport in proximal as well as in distal tubules.
将钒酸盐、呋塞米、氯噻嗪、乙酰唑胺和氨氯吡咪同时注入清醒大鼠体内,以确定肾钠重吸收能够被抑制的程度。尽管尿流率极高,但通过静脉输注足以维持体重恒定的等渗盐溶液,动物们保持了精确的液体平衡。在最大有效剂量下,钒酸盐、呋塞米、氯噻嗪、乙酰唑胺和氨氯吡咪使钠排泄量增加至等于滤过负荷的69%。这些药物与相当于体重7%的等渗细胞外液扩张一起,使钠排泄量增加至等于滤过负荷的83.7%,这是哺乳动物中此前未报道过的持续钠排泄水平。这些研究表明,在体内,近端和远端小管中减少钠和水转运的药物可显著抑制肾小管对钠和水的重吸收。